Literature DB >> 15165700

Increased caveolin-1 expression in Alzheimer's disease brain.

Sophie B Gaudreault1, Doris Dea, Judes Poirier.   

Abstract

Increasing evidence suggests that cholesterol plays a central role in the pathophysiology of Alzheimer's disease (AD). Caveolin is a cholesterol-binding membrane protein involved in cellular cholesterol transport. We investigated the changes in the protein amount of hippocampal caveolin of autopsy-confirmed AD and aged-matched control subjects. Our results demonstrate that caveolin protein levels in the hippocampus and caveolin mRNA in the frontal cortex are up-regulated in AD by approximately two-fold, compared to control brains. These results suggest a relationship between caveolin-1 expression levels and a dysregulation of cholesterol homeostasis at the plasma membrane of brain cells. In support of this hypothesis, a significant increase in caveolin protein levels has also been observed in hippocampal tissue from ApoE-deficient (knockout) and aged wild-type mice; two situations associated with modifications of transbilayer distribution of cholesterol in brain synaptic plasma membranes. These results indicate that caveolin over-expression is linked to alterations of cholesterol distribution in the plasma membrane of brain cells and are consistent with the notion of a deterioration of cholesterol homeostasis in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165700     DOI: 10.1016/j.neurobiolaging.2003.07.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

1.  SorLA in glia: shared subcellular distribution patterns with caveolin-1.

Authors:  Iris K Salgado; Melissa Serrano; José O García; Namyr A Martínez; Héctor M Maldonado; Carlos A Báez-Pagán; José A Lasalde-Dominicci; Walter I Silva
Journal:  Cell Mol Neurobiol       Date:  2011-11-30       Impact factor: 5.046

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 3.  White matter rafting--membrane microdomains in myelin.

Authors:  Lillian S Debruin; George Harauz
Journal:  Neurochem Res       Date:  2006-09-21       Impact factor: 3.996

4.  Directed evolution and biophysical characterization of a full-length, soluble, human caveolin-1 variant.

Authors:  Joshua N Smith; Joshua M Edgar; J Mark Balk; Mariam Iftikhar; Jessica C Fong; Tivoli J Olsen; Dmitry A Fishman; Sudipta Majumdar; Gregory A Weiss
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-05-29       Impact factor: 3.036

5.  Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo.

Authors:  Cory D Sago; Melissa P Lokugamage; Gwyneth N Lando; Naima Djeddar; Nirav N Shah; Chris Syed; Anton V Bryksin; James E Dahlman
Journal:  Nano Lett       Date:  2018-09-20       Impact factor: 11.189

Review 6.  Caveolin proteins and estrogen signaling in the brain.

Authors:  Jessie I Luoma; Marissa I Boulware; Paul G Mermelstein
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

Review 7.  Caveolin proteins: a molecular insight into disease.

Authors:  Hongli Yin; Tianyi Liu; Ying Zhang; Baofeng Yang
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

8.  Probing the U-shaped conformation of caveolin-1 in a bilayer.

Authors:  Huan Rui; Kyle T Root; Jinwoo Lee; Kerney Jebrell Glover; Wonpil Im
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

9.  Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar/lipid raft pathway.

Authors:  Anna Francesconi; Ranju Kumari; R Suzanne Zukin
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

10.  Paired hormone response elements predict caveolin-1 as a glucocorticoid target gene.

Authors:  Marinus F van Batenburg; Hualing Li; J Annelies Polman; Servane Lachize; Nicole A Datson; Harmen J Bussemaker; Onno C Meijer
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.